Table 1 Governance committees comprising the TRM-SLE Taskforce
Committee | Members | Role |
|---|---|---|
Steering Committee | 35 members: Core research team (principal investigator, clinician–researchers and fellows, methodology experts) Patient and/or patient-organization representatives Industry representatives Metrology and regulatory experts Additional clinician–researchers with relevant expertise | Responsible for the scientific direction and delivery of the project |
Scientific Advisory Board | 29 members: Clinician–researchers with relevant expertise Patient and/or patient-organization representatives Industry representatives | Provide additional scientific input and oversight |
Patient Advisory Panel | 16 members: Patients with SLE Patient-organization representatives (Lupus Foundation of America and Lupus Europe) | Provide guidance regarding the patient experience of SLE via direct involvement and oversight of instrument development |
Industry Advisory Board | 28 members: Representatives from 10 industry partners with relevant expertise | Advise on industry-specific matters including leading regulatory engagement |
